Beacon Investment Advisory Services, Inc. Ampio Pharmaceuticals, Inc. Transaction History

Beacon Investment Advisory Services, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.42 - $0.62 $71,587 - $105,677	-170,447 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$0.56 - $1.71 $14,280 - $43,605	25,500 Added 17.59%	170,447 $97,000
Q3 2021 Nov 09, 2021	BUY	$1.21 - $1.8 $126,985 - $188,904	104,947 Added 262.37%	144,947 $241,000
Q1 2021 May 21, 2021	BUY	$1.36 - $2.49 $13,600 - $24,900	10,000 Added 33.33%	40,000 $68,000
Q3 2020 Oct 29, 2020	BUY	$0.61 - $1.17 $18,300 - $35,100	30,000 New	30,000 $29,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.